Wednesday, July 8, 2026

Drug profile · INN

invert sugar

invert sugar (TRAVERT 10% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — invert sugar
US status
approved
Class
Route
INJECTION
Patents
0
Programs
1
Data quality
0.84

Quick answer

invert sugar (TRAVERT 10% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN invert sugar
Brand TRAVERT 10% IN PLASTIC CONTAINER
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Sugar Pill Phase 1 · BRIGHT MINDS BIOSCIENCES · Substance-Related Disorders

Frequently asked questions

What is invert sugar?

invert sugar (TRAVERT 10% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for invert sugar?

TRAVERT 10% IN PLASTIC CONTAINER is a marketed brand name for invert sugar. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of invert sugar?

invert sugar has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.